These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30455642)

  • 1. Role of Alternative Lipid Excipients in the Design of Self-Nanoemulsifying Formulations for Fenofibrate: Characterization,
    Alshamsan A; Kazi M; Badran MM; Alanazi FK
    Front Pharmacol; 2018; 9():1219. PubMed ID: 30455642
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
    Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
    Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) Containing Rice Bran Oil for Enhanced Fenofibrate Oral Delivery: In Vitro Digestion, Ex Vivo Permeability, and In Vivo Bioavailability Studies.
    Karavasili C; Andreadis II; Tsantarliotou MP; Taitzoglou IA; Chatzopoulou P; Katsantonis D; Zacharis CK; Markopoulou C; Fatouros DG
    AAPS PharmSciTech; 2020 Jul; 21(6):208. PubMed ID: 32725343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Poorly Water-Soluble Talinolol: Preparation,
    Kazi M; Al-Swairi M; Ahmad A; Raish M; Alanazi FK; Badran MM; Khan AA; Alanazi AM; Hussain MD
    Front Pharmacol; 2019; 10():459. PubMed ID: 31118895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using in vitro lipolysis and SPECT/CT in vivo imaging to understand oral absorption of fenofibrate from lipid-based drug delivery systems.
    Tran T; Bønløkke P; Rodríguez-Rodríguez C; Nosrati Z; Esquinas PL; Borkar N; Plum J; Strindberg S; Karagiozov S; Rades T; Müllertz A; Saatchi K; Häfeli UO
    J Control Release; 2020 Jan; 317():375-384. PubMed ID: 31765705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol.
    Kazi M; Alqahtani A; Alharbi M; Ahmad A; Hussain MD; Alothaid H; Aldughaim MS
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus.
    Kazi M; Alqahtani A; Ahmad A; Noman OM; Aldughaim MS; Alqahtani AS; Alanazi FK
    Drug Deliv; 2021 Dec; 28(1):100-114. PubMed ID: 33345632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension treatment.
    Usta DY; Timur B; Teksin ZS
    Eur J Pharm Sci; 2022 Jul; 174():106159. PubMed ID: 35263632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization.
    Larsen AT; Ogbonna A; Abu-Rmaileh R; Abrahamsson B; Ostergaard J; Müllertz A
    Pharmaceutics; 2012 Dec; 4(4):641-65. PubMed ID: 24300374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
    Thomas N; Holm R; Müllertz A; Rades T
    J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability.
    Gamal W; Fahmy RH; Mohamed MI
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1530-1538. PubMed ID: 28447878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Customized Screening Tool Approach for the Development of a Self-Nanoemulsifying Drug Delivery System (SNEDDS).
    Schmied FP; Bernhardt A; Engel A; Klein S
    AAPS PharmSciTech; 2021 Dec; 23(1):39. PubMed ID: 34961897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
    Mohsin K
    AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.
    Kollipara S; Gandhi RK
    Acta Pharm Sin B; 2014 Oct; 4(5):333-49. PubMed ID: 26579403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Evaluation of a Solid Supersaturated Self Nanoemulsifying Drug Delivery System (Super-SNEDDS) of Aprepitant for Enhanced Solubility.
    Nazlı H; Mesut B; Özsoy Y
    Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
    Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S
    Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient.
    Patki M; Patel K
    Drug Dev Ind Pharm; 2019 Mar; 45(3):405-414. PubMed ID: 30444435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Pingkai O
    Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of self nanoemulsifying drug delivery system for poorly water-soluble drug using response surface methodology.
    Ren S; Mu H; Alchaer F; Chtatou A; Müllertz A
    Drug Dev Ind Pharm; 2013 May; 39(5):799-806. PubMed ID: 22871082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.